Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

about

Clinical commentary on "Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab".Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab.

P2860

Q40148365-58F90B47-477B-4D9C-9E79-D520843BC863 Q49906338-C5C21134-524C-4068-B6EB-C8A5583C83E6 Q55561425-B145955A-E7EC-4978-BD51-6CB26F19CC84

P2860

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

Item

http://www.wikidata.org/entity/Q40160845

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Varicella-zoster meningovascul ...... ient treated with natalizumab.

@en

type

Item

label

Varicella-zoster meningovascul ...... ient treated with natalizumab.

@en

prefLabel

Varicella-zoster meningovascul ...... ient treated with natalizumab.

@en

P1476

Varicella-zoster meningovascul ...... tient treated with natalizumab

@en

P2093

Alex Rovira

http://www.w3.org/2001/XMLSchema#string

Cristina Auger

http://www.w3.org/2001/XMLSchema#string

Laura Parolin

http://www.w3.org/2001/XMLSchema#string

Patricia Mulero

http://www.w3.org/2001/XMLSchema#string

P2860

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.

Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.

Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.

Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.

Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.

Significant clinical worsening after natalizumab withdrawal: Predictive factors

P304

358-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458517711569

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28643544

http://www.w3.org/2001/XMLSchema#string

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

about

P2860

P2860

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698